U.S. Water Utilities Stock News

NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Assessing Texas Capital Bancshares (TCBI) Valuation After Strong Results And Upbeat 2026 Guidance

Texas Capital Bancshares (TCBI) is back in focus after a strong fourth quarter and full year 2025, where earnings and revenue topped market expectations and management issued upbeat 2026 guidance. See our latest analysis for Texas Capital Bancshares. That upbeat earnings report, new 2026 guidance and a refreshed buyback plan have arrived alongside a 30 day share price return of 9.91% and a 90 day share price return of 20.50%, while the 1 year total shareholder return of 27.40% points to...
NYSE:AON
NYSE:AONInsurance

Does Aon (AON) Share Price Reflect Its Role In Global Risk Management?

If you are wondering whether Aon shares at around US$342.95 still make sense for your portfolio, the key question is how that price lines up with the underlying value of the business. The stock has had mixed returns, with a 2.1% gain over the past week but a 3.8% decline over the last month and a 7.1% decline over the past year, which can change how investors view its growth potential and risk profile. Recent news coverage has largely focused on Aon's position as a major global insurance...
NYSE:TNC
NYSE:TNCMachinery

Should Tennant’s Two-Year Sales Stall and EPS Decline Require Action From Tennant (TNC) Investors?

In recent commentary, Tennant reported that sales have effectively flatlined over the past two years, while earnings per share have fallen each year. This combination of stagnating revenue and shrinking profitability suggests Tennant may need to rethink how it drives both demand and margins. Next, we will examine how Tennant’s stagnating sales backdrop shapes the company’s broader investment narrative and potential growth story. Uncover the next big thing with financially sound penny...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Assessing Liquidia (LQDA) Valuation After New Pulmonary Hypertension Data Plans For PVRI 2026

Liquidia (LQDA) recently announced it will share interim and open label clinical data for LIQ861, branded as YUTREPIA, and investigational L606 at the PVRI 2026 Annual Congress, giving investors fresh detail on its pulmonary hypertension pipeline. See our latest analysis for Liquidia. The PVRI 2026 data update comes after a strong run in Liquidia’s share price, with a 30 day share price return of 25.07% and a 90 day share price return of 76.77%, while the 1 year total shareholder return is...
NYSE:PII
NYSE:PIILeisure

Assessing Polaris (PII) Valuation After Recent Share Price Pullback And Conflicting Fair Value Signals

With no single headline event driving Polaris (PII) today, investors are instead focusing on the stock’s recent returns and fundamentals, including revenue of US$7,236.3m and a reported net loss of US$465.5m. See our latest analysis for Polaris. Polaris shares trade at US$64.68 after a recent 7 day share price decline of 8.8%, while the 1 year total shareholder return of 39.3% contrasts with weaker 3 and 5 year total shareholder returns that point to fading longer term momentum. If Polaris...
NYSE:ICE
NYSE:ICECapital Markets

Intercontinental Exchange Turns Reddit Chatter Into AI Market Data Opportunity

Intercontinental Exchange (NYSE:ICE) has launched Reddit Signals and Sentiment, an AI powered data suite that turns Reddit discussions into market intelligence for investors. The product is designed to translate crowdsourced conversations into near real time sentiment indicators that can be used alongside traditional financial data. The launch highlights ICE’s push to expand its data and analytics offerings beyond its core exchange and clearing services. Intercontinental Exchange operates...
NYSE:AWK
NYSE:AWKWater Utilities

Is American Water Works Company (AWK) Pricing Look Stretched After Recent Share Weakness

If you are wondering whether American Water Works Company is offering fair value at around US$129 per share today, this article walks through what the current price might imply about the stock. The stock has recorded a 1.9% decline over the last 7 days, a 1.6% decline over 30 days and a 1.0% decline year to date, while the 1-year return sits at 6.9%. The 3-year and 5-year returns are 14.2% and 13.3% declines, respectively. Recent interest in American Water Works Company has been shaped by...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON) Margin Decline Tests Bullish Earnings Growth Narratives

Honeywell International (HON) closed out FY 2025 with fourth quarter revenue of US$9.8b and basic EPS of US$0.49, alongside earnings from discontinued operations of US$17m and net income excluding extra items of US$312m, setting a measured tone for the full year. Over the past six quarters, the company has seen quarterly revenue move between US$9.7b and US$10.4b, while basic EPS ranged from US$0.49 to roughly US$2.87, giving investors a clear view of how earnings power has shifted against a...
NYSE:BC
NYSE:BCLeisure

Brunswick (BC) Q4 Return To Profit Tests Bullish Earnings Recovery Narrative

Brunswick (BC) has just posted its FY 2025 numbers with Q4 revenue of US$1.3b and basic EPS of US$0.28, alongside net income from continuing operations of US$18.6m. The company has seen quarterly revenue move from US$1.15b in Q4 2024 to US$1.33b in Q4 2025, while basic EPS shifted from a loss of US$1.07 per share in Q4 2024 to a profit of US$0.28 in Q4 2025. This sets up a results season where the key question is how durable these margins look against a still loss making trailing twelve month...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Valuation Check After Recent Rebrand And Mixed Share Price Performance

Penguin Solutions overview after recent rebrand Penguin Solutions (PENG) is drawing fresh attention after its recent name change from SMART Global Holdings, shifting the focus to its enterprise computing, memory, and LED businesses, while the share price has been mixed over the past year. See our latest analysis for Penguin Solutions. Since the rebrand, Penguin Solutions’ share price return has been softer, with a 7 day share price return showing a 4.8% decline and a 90 day share price return...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Plexus (PLXS) TTM Earnings Surge Of 45.7% Tests Bullish Growth Narratives

Plexus (PLXS) opened fiscal Q1 2026 with revenue of US$1.1b and basic EPS of US$1.54, while trailing twelve month basic EPS stood at US$6.56 on revenue of US$4.1b, setting a clear earnings season backdrop for investors. Over the past year, the company has seen revenue move from US$3.96b to US$4.1b on a trailing basis, with basic EPS rising from US$4.08 to US$6.56, giving investors a fuller view of how the latest quarterly print fits within the recent earnings run and margin profile. See our...
NYSE:CW
NYSE:CWAerospace & Defense

Should Curtiss-Wright’s Hybrid Cloud Avionics Push With Green Hills Shape CW’s Defense Investment Narrative?

Curtiss-Wright recently expanded its defense and aerospace footprint through a collaboration with Green Hills Software on a high-performance, safety-certifiable COTS computing solution for critical avionics, alongside earlier validation of its PacStar tactical edge servers for Azure Local in November 2025. By pairing safety-certifiable avionics computing with cloud-enabled tactical edge servers, Curtiss-Wright is positioning its portfolio at the intersection of mission-critical reliability...
NYSE:GEV
NYSE:GEVElectrical

GE Vernova (GEV) Earnings Surge And 12.8% Margin Test Rich Valuation Narratives

GE Vernova (GEV) closed out FY 2025 with Q4 revenue of US$10.96b and basic EPS of US$13.57, alongside net income excluding extra items of US$3,664m, capping a year in which trailing twelve month EPS reached US$17.96 on revenue of US$38.07b. Over the past six quarters, the company has seen quarterly revenue move from US$8,913m in Q3 2024 to US$10,558m in Q4 2024 and then to US$10,956m in Q4 2025, while basic EPS shifted from a loss of US$0.35 in Q3 2024 to US$1.75 in Q4 2024 and then to...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

Is BOND-003’s Phase 3 Progress Reshaping The Investment Case For CG Oncology (CGON)?

CG Oncology has been gaining attention as its flagship BOND-003 therapy progresses through phase 3 trials for high-risk BCG-unresponsive non-muscle invasive bladder cancer, aiming to offer a bladder-sparing treatment option. The company’s focus on addressing this difficult-to-treat patient group highlights its potential role in reshaping how bladder cancer is managed if trial outcomes support its approach. Next, we’ll examine how the advanced phase 3 progress of BOND-003 shapes CG Oncology’s...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Converging Analyst Upgrades on PTC’s Rare Disease Pipeline Might Change The Case For Investing In PTC Therapeutics (PTCT)

In recent days, Barclays upgraded PTC Therapeutics to an Overweight rating, while other brokers continued to rate the biotech as Outperform, underscoring growing analyst optimism around the company’s rare disease portfolio. This convergence of positive views, anchored in PTC’s therapies for conditions such as Duchenne muscular dystrophy and AADC deficiency, highlights how analyst sentiment can crystallize around a focused clinical pipeline. Next, we’ll examine how this strengthened analyst...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust Headquarters Move Adds Context To Cost And Execution Story

Medical Properties Trust (NYSE:MPW) has relocated its corporate headquarters to a new address in Alabama. The move marks an official change in the company’s primary base of operations. Medical Properties Trust focuses on investing in hospital and healthcare facilities, with tenants that operate across a range of medical services. A headquarters relocation can affect how leadership is organized, how teams work together and how resources are allocated across the portfolio. For you as an...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

Assessing POET Technologies (NasdaqCM:POET) Valuation After Its Recent Follow On Offering And Shelf Registration

POET Technologies (NasdaqCM:POET) has drawn fresh attention after completing a US$150.000006 million registered direct follow on equity offering at US$7.25 per share, issuing 20,689,656 new common shares to investors. See our latest analysis for POET Technologies. The follow on offering and shelf registration have arrived during a weaker patch for the stock, with a 7 day share price return of 14.27% decline and a year to date share price return of 16.90% decline. However, the 1 year total...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Technologies (LHX) Net Margin Steady At 7.3% Reinforces Measured Bullish Narratives

L3Harris Technologies (LHX) closed out FY 2025 with fourth quarter revenue of US$5.6b and basic EPS of US$1.60, alongside net income of US$300m, while trailing twelve month EPS stood at US$8.57 on revenue of US$21.9b and net income of US$1.6b. Over the past six quarters, the company has seen quarterly revenue move from US$5.3b in Q3 2024 to US$5.6b in Q4 2025, with basic EPS ranging between US$1.60 and US$2.47 and net income between US$300m and US$462m, setting a clear earnings profile for...
NYSE:SHW
NYSE:SHWChemicals

Sherwin Williams (SHW) Margin Compression Challenges Premium 34x P E Narrative

Sherwin-Williams (SHW) has wrapped up FY 2025 with fourth quarter revenue of US$5,595.9 million and basic EPS of US$1.94, alongside trailing twelve month revenue of US$23.6 billion and EPS of US$10.37 that frame the full year earnings picture. Over recent periods, revenue has moved from US$5,297.2 million in Q4 2024 to US$5,595.9 million in Q4 2025, while quarterly EPS has been reported at US$1.92 and US$1.94 respectively, giving investors a clear read on how top line and per share profits...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

First Financial Bancorp (FFBC) Earnings Growth Acceleration Challenges Cautious Narratives

First Financial Bancorp (FFBC) closed out FY 2025 with fourth quarter revenue of US$228.7 million and EPS of US$0.65. Trailing twelve month revenue was US$861.8 million and EPS was US$2.68. Over the past year, the company’s revenue increased from US$756.1 million to US$861.8 million and EPS moved from US$2.42 to US$2.68. This coincided with earnings growth of 11.7% over the last 12 months, compared with a 5-year average of 6.8% per year. Investors may weigh this growth and a 3.47% dividend...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

IonQ SkyWater Deal Puts Quantum Ambitions And Shareholder Value Under Review

IonQ has entered a definitive agreement to acquire SkyWater Technology (NasdaqCM:SKYT), aiming to build a vertically integrated full stack quantum and semiconductor platform in the United States. The combined company is expected to focus on quantum chip development and manufacturing capabilities for government and commercial customers. Multiple law firms have launched investigations into whether the transaction terms and process are fair to SkyWater shareholders. For you as an investor,...
NYSE:JBL
NYSE:JBLElectronic

Is It Too Late To Consider Jabil (JBL) After Its Strong Multi Year Rally?

If you are wondering whether Jabil's share price still offers value, or if most of the opportunity is already reflected in the stock, this article walks through what the numbers indicate about where the price stands today. The stock last closed at US$243.92, with returns of 5.3% over 30 days, 1.5% year to date, 50.2% over 1 year, a gain of about 3x over 3 years, and an even larger gain over 5 years. Recent coverage has focused on Jabil's positioning in electronics manufacturing and supply...
NasdaqGS:HWBK
NasdaqGS:HWBKBanks

Hawthorn Bancshares (HWBK) Margin Improvement To 29.8% Tests Cautious Earnings Narratives

Hawthorn Bancshares (HWBK) has wrapped up FY 2025 with fourth quarter revenue of US$20.8 million and EPS of US$0.90, set against trailing 12‑month revenue of US$79.9 million and EPS of US$3.44 that came with 30.4% earnings growth over the past year. The company has seen revenue move from US$71.9 million and EPS of US$2.61 on a trailing basis a year ago to the latest US$79.9 million and US$3.44, while quarterly revenue has ranged between US$16.7 million and US$20.8 million through 2025. With...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

A Look At Farmers National Banc (FMNB) Valuation After Recent Share Price Weakness

Farmers National Banc (FMNB) is back on investors’ radar after recent share price moves, with the stock closing at $12.85 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Farmers National Banc. At a share price of $12.85, Farmers National Banc has seen short term weakness, with a 7 day share price return of a 7.62% decline, while longer term total shareholder returns over three and five years sit at 2.99% and 14.51% respectively. This may...